Citrini Research and Anthropic Test Claude-Designed Proteins Against Scorpion Toxins
Citrini Research and Anthropic report that an internal Claude model autonomously designed 211 protein minibinders against five scorpion neurotoxins, with 17 binding in lab tests, prompting Citrini to back life sciences stocks, though blocking effects remain untested.
5newsrooms
5articles
47 hoursrunning
Oct 20first seen
Ask Scout
Scout answers questions about this story using only the coverage below.
Coverage over time
Articles
| Oct 22, 5:21 AM | theverge.com | Claude did not invent scorpion antivenom |
| Oct 21, 2:55 AM | techmeme.com | Anthropic and Citrini Research use an internal Claude model to autonomously generate protein minibinders against five scorpion neurotoxins, testing 211 designs (Anthropic) |
| Oct 20, 12:35 PM | marketwatch.com | Wall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis. |
| Oct 20, 7:01 AM | qz.com | Citrini Research is backing life sciences stocks after using Claude to design proteins |
| Oct 20, 6:00 AM | bloomberg.com | Citrini Bets on Life Sciences Stocks After Claude AI Drug Study |